KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...

LAWRENCEVILLE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it will ...

INOVIO (NASDAQ: INO) announced that results from its Phase 1 proof-of-concept trial evaluating DNA-encoded monoclonal antibodies (DMAbs) for COVID-19 have been published in Nature Medicine. The ...

The Company treated the first patient in the pivotal Phase 3 OVATION 3 Study in July 2025 and is working with trial investigators to expand clinical sites and accelerate enrollment. Four sites have ...

The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative ...

【pg娱乐电子游戏官网最新版】tianliyl.com|rb826.com:9900|www.18588kk.com|xpj5266.com|7jhf4ygp.umk22w7j09.cc|k88109.com|6563hhh.com-该片根据浙江籍女 ...

And it did kill poor Ralph, ' said Mr Carrisford. 'He put all his money into the mines because I was his friend., ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...

2025-11-02 08:01:26 The results also show that enterprise's R&D investment (technology development) and external technology ...

State Key Laboratory for Quality and Safety of Agro-Products, Key Laboratory of Biotechnology in Plant Protection of MARA, Zhejiang Key Laboratory of Green Plant Protection, Institute of Plant ...

\It takes 6, 000 to 14, 000 parts to make a vehicle, \ says Sean McAlinden, CAR's chief economist. \If you don't have one, ...